{"id":"W2114875729","doi":"10.1186/s12955-014-0104-5","title":"Patient-reported outcome labeling claims and measurement approach for metastatic castration-resistant prostate cancer treatments in the United States and European Union","year":2014,"lang":"en","type":"article","venue":"Health and Quality of Life Outcomes","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":26,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"","keywords":"Medicine; Prostate cancer; Cabazitaxel; European union; Enzalutamide; Patient-reported outcome; Quality of life (healthcare); Brief Pain Inventory; Family medicine; Cancer; Physical therapy; Internal medicine; Androgen deprivation therapy; Chronic pain; Business","routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.1265783,0.0005051967,0.0009004947,0.01044531,0.0007552991,0.003240502,0.001504929,0.001249536,0.002179012],"category_scores_gemma":[0.1802695,0.000250151,0.002375196,0.01025483,0.001437287,0.001980811,0.002144656,0.00157131,0.0003456657],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.004453252,"about_ca_system_score_gemma":0.005362482,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.003121309,"about_ca_topic_score_gemma":0.002948452,"domain_scores_codex":[0.8685069,0.08110002,0.01968233,0.004860155,0.02497937,0.0008711601],"domain_scores_gemma":[0.756413,0.1178542,0.08393086,0.006435162,0.03408096,0.001285794],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.003846077,0.00124566,0.5890186,0.01057533,0.003054209,0.0003070202,0.004276201,0.002911893,0.001445858,0.02098125,0.01576146,0.3465765],"study_design_scores_gemma":[0.0006108154,0.004397726,0.8695679,0.007614204,0.002697675,0.0009659832,0.003430796,0.007464515,0.003166467,0.008786089,0.0910933,0.0002046022],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.6607612,0.1226337,0.06509601,0.02007397,0.001460663,0.009777843,0.0289156,0.0003252132,0.09095574],"genre_scores_gemma":[0.9421595,0.008406887,0.02845873,0.003672154,0.000421573,0.007343908,0.008452444,0.00004876511,0.00103602],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1265783,"threshold_uncertainty_score":0.669418,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.2694615134421238,"score_gpt":0.4301721743707721,"score_spread":0.1607106609286483,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}